2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of visits for which the eligible clinician attestsContinue reading “2025 #130 MIPS Measure Documentation of Current Medications in the Medical Record”
CQMS Archive
2025 #128 MIPS Measure Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) – MIPS VALUE PATHWAYS (MVP) REPORTING ONLY MEASURE TYPE: Process Description: Percentage of patients aged 18Continue reading “2025 #128 MIPS Measure Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan”
2025 #127 MIPS Measure Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2025 #127 MIPS Measure Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear”
2025 #126 MIPS Measure Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy — Neurological Evaluation
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2025 #126 MIPS Measure Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy — Neurological Evaluation”
2025 #118 MIPS Measure Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – Diabetes or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis of coronaryContinue reading “2025 #118 MIPS Measure Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – Diabetes or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)”
2025 #117 MIPS Measure Diabetes: Eye Exam
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients 18-75 years of age with diabetes and an activeContinue reading “2025 #117 MIPS Measure Diabetes: Eye Exam”
2025 #116 MIPS Measure Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: The percentage of episodes for patients ages 3 monthsContinue reading “2025 #116 MIPS Measure Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis”
2025 #113 MIPS Measure Colorectal Cancer Screening
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) – MIPS VALUE PATHWAYS (MVP) REPORTING ONLY MEASURE TYPE: Process Description: Percentage of patients 45-75 yearsContinue reading “2025 #113 MIPS Measure Colorectal Cancer Screening”
2025 #112 MIPS Measure Breast Cancer Screening
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) – MIPS VALUE PATHWAYS (MVP) REPORTING ONLY MEASURE TYPE: Process Description: Percentage of women 40 –Continue reading “2025 #112 MIPS Measure Breast Cancer Screening”
2025 #102 MIPS Measure Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of patients, regardless of age, with a diagnosisContinue reading “2025 #102 MIPS Measure Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients”